Stoke Therapeutics, Inc. (STOK) Net margin 2022–2025
Stoke Therapeutics, Inc. (STOK) net profit margin by fiscal year — reported net income divided by reported revenue.
-3.7%FY2025 · since FY2022: -814.7% → -3.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3.7% | +239.7 pp |
| FY2024 | -243.4% | +949.1 pp |
| FY2023 | -1192.5% | -377.7 pp |
| FY2022 | -814.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice